{ "schemaVersion": 2, "eyebrow": "Cardiac Electrophysiology", "title": "Atrial Flutter", "summary": "Atrial flutter requires rapid distinction between hemodynamic instability, typical cavotricuspid-isthmus–dependent flutter amenable to ablation, and atypical post–left atrial ablation circuits. Stroke prevention follows atrial fibrillation principles, while long-term surveillance remains essential after apparently successful flutter ablation.", "seoDescription": "Point-of-care management of atrial flutter: ECG classification, cardioversion, anticoagulation, CTI ablation, atypical flutter mapping, and follow-up.", "clinicalQuestion": "How should physicians classify, stabilize, anticoagulate, treat, and monitor patients with atrial flutter?", "specialty": "Cardiology", "audience": "U.S. physicians and medical trainees", "tags": [ "atrial flutter", "typical atrial flutter", "cavotricuspid isthmus ablation", "atrial flutter anticoagulation", "atypical atrial flutter", "cardioversion" ], "keyTakeaways": [ "Treat atrial flutter as an arrhythmia with immediate hemodynamic and thromboembolic implications; management includes rate or rhythm control plus anticoagulation according to risk. [4][10][21]", "Negative flutter waves in inferior leads with positive V1 morphology support counterclockwise typical flutter, but ECG morphology can be misleading after prior left atrial ablation. [14][15][8]", "Typical flutter is cavotricuspid-isthmus dependent and is generally amenable to an anatomic CTI ablation strategy, including when flutter is not present during the procedure. [14]", "After flutter ablation, do not equate sinus rhythm with elimination of thromboembolic risk: incident atrial fibrillation is common, and long-term stroke has been reported. [21]", "For flutter arising after left atrial atrial fibrillation ablation, assess CTI dependence early with entrainment mapping even when the ECG lacks typical inferior-lead negativity. [8]" ], "sections": [ { "id": "initial-triage", "eyebrow": "Immediate decision", "heading": "Stabilize first and identify patients needing urgent rhythm restoration", "intro": "The first decision is whether the ventricular response is causing acute instability or ventricular dysfunction.", "paragraphs": [ "Obtain a 12-lead ECG and assess blood pressure, ischemic symptoms, pulmonary edema, syncope, and end-organ hypoperfusion. A regular ventricular rate near 150 beats/min should prompt consideration of flutter with 2:1 AV conduction, because typical flutter often has an atrial rate of 250 to 350 beats/min and a regular ventricular response near 150 beats/min. [15]", "When atrial flutter accompanies clinical deterioration, prioritize restoration of hemodynamic stability rather than prolonged attempts at outpatient-style rate control. Atrial tachyarrhythmias can both reflect and worsen underlying cardiac disease, including tachycardia-induced ventricular dysfunction and heart failure. [10]", "In a stable patient, make two parallel decisions: control the ventricular rate or restore sinus rhythm based on symptoms and clinical context, and assess thromboembolic risk before cardioversion or long-term rhythm management. Guideline-based AF management includes rate or rhythm control and anticoagulation in higher-risk patients; the same thromboembolic framework is clinically relevant to atrial flutter. [4][10][21]" ], "bullets": [ "Obtain 12-lead ECG before intervention when feasible; preserve the tracing for flutter morphology classification and later electrophysiology planning. [14][15]", "Perform transthoracic echocardiography when new flutter is accompanied by heart failure, suspected structural disease, or concern for tachycardia-mediated ventricular dysfunction; flutter and AF frequently coexist with hypertension, coronary disease, valvular disease, heart failure, obesity, sleep apnea, and pulmonary disease. [4][10]", "If tachycardia persists or is recurrent, reassess left ventricular function because sustained atrial tachyarrhythmia can contribute to potentially reversible ventricular dysfunction. [9][10]" ], "subsections": [], "table": { "caption": "Initial atrial flutter decisions", "columns": [ "Clinical finding", "Interpretation", "Next action" ], "rows": [ [ "Hypotension, ischemic symptoms, pulmonary edema, syncope, or hypoperfusion during flutter", "Hemodynamically consequential tachyarrhythmia", "Prioritize urgent rhythm restoration and treatment of the concurrent clinical syndrome. [10]" ], [ "Regular ventricular rate near 150 beats/min", "Suggests possible 2:1 conduction during flutter", "Inspect atrial activity across all ECG leads and obtain a diagnostic 12-lead tracing. [15]" ], [ "New heart failure or reduced ejection fraction with persistent tachycardia", "Consider tachycardia-mediated cardiomyopathy", "Pursue durable rate or rhythm control and reassess ventricular function after arrhythmia control. [9][10]" ] ] } }, { "id": "ecg-classification", "eyebrow": "Mechanism directs procedure", "heading": "Classify typical versus atypical flutter before selecting an ablation strategy", "intro": "ECG morphology can guide the likely circuit, but prior atrial intervention changes its reliability.", "paragraphs": [ "Counterclockwise typical atrial flutter is a right-atrial macroreentrant circuit around the tricuspid annulus that depends on slow conduction through the cavotricuspid isthmus between the tricuspid annulus and inferior vena cava. The usual ECG pattern is continuous negative flutter waves in the inferior leads with positive flutter activity in V1; atrial rate is typically 250 to 350 beats/min. [14][15]", "Clockwise, or reverse typical, flutter remains CTI dependent but has reciprocal surface morphology: flutter waves may be positive in the inferior leads with a broad negative V1 deflection. This distinction matters because both clockwise and counterclockwise typical circuits can be approached through CTI ablation rather than left-atrial substrate ablation. [15][14]", "Do not classify a post–atrial fibrillation ablation flutter as left atrial solely because the ECG is nonclassic. Among patients presenting with flutter after left atrial ablation, 60% of those with CTI-dependent flutter had upright inferior-lead flutter waves; early CTI entrainment mapping can avoid unnecessary transseptal access and left-atrial mapping. [8]", "Atypical flutter is particularly likely after prior catheter ablation or surgical Maze procedures, where incomplete ablation lines can support circuits involving the anterior wall, roof, or septum of the left atrium. Low-voltage regions may complicate mapping, so refer recurrent or postablation flutter for an electrophysiology strategy based on activation and entrainment mapping rather than surface ECG alone. [15][8]" ], "bullets": [ "Typical counterclockwise pattern: negative inferior-lead flutter waves, positive V1, and no isoelectric interval between flutter waves. [15]", "Typical clockwise pattern: positive inferior-lead flutter waves with broad negative V1 morphology. [15]", "After prior left atrial ablation: perform CTI entrainment early even with atypical ECG morphology; CTI dependence remains possible. [8]" ], "subsections": [], "table": { "caption": "Circuit-oriented classification of atrial flutter", "columns": [ "Pattern", "Supporting clues", "Procedural implication" ], "rows": [ [ "Counterclockwise typical flutter", "Negative inferior-lead flutter waves and positive V1; right-atrial macroreentry around the tricuspid annulus. [14][15]", "CTI-dependent circuit; use an anatomic CTI ablation approach. [14]" ], [ "Clockwise typical flutter", "Positive inferior-lead activity and broad negative V1; reverse-direction CTI-dependent reentry. [15]", "CTI ablation remains the relevant lesion set. [14][15]" ], [ "Flutter after AF ablation with nonclassic ECG", "Inferior leads may be upright despite CTI dependence. [8]", "Test CTI dependence with entrainment before proceeding to transseptal left-atrial mapping. [8]" ], [ "Atypical left-atrial flutter", "Often follows incomplete surgical Maze or catheter-ablation lines; roof, anterior-wall, or septal circuits are described. [15]", "Require detailed electrophysiologic mapping; do not assume CTI ablation alone will terminate the circuit. [15]" ] ] } }, { "id": "stroke-prevention", "eyebrow": "Thromboembolism", "heading": "Apply anticoagulation and cardioversion planning as for atrial fibrillation", "intro": "Rhythm conversion does not remove the need to evaluate sustained thromboembolic risk.", "paragraphs": [ "Assess stroke and systemic embolism risk as part of every flutter encounter, particularly before cardioversion, ablation, or discontinuation of anticoagulation. Contemporary AF guidance specifically addresses thromboembolic risk assessment, anticoagulants, temporary interruption of therapy, and left atrial appendage occlusion; atrial flutter management is incorporated into the same guideline framework. [21][22][23]", "Avoid using a successful CTI ablation as the sole reason to stop surveillance or to assume thromboembolic risk has resolved. In one study, 38% developed new-onset AF after flutter ablation and thromboembolic events occurred in 10% during mean 5-year follow-up; a Danish registry reported stroke in 5% and death in 10% during mean 4-year follow-up after flutter ablation. [21]", "Continue longitudinal reassessment because AF and flutter commonly coexist and postablation AF is more likely in patients with left-atrial enlargement, inducible AF at flutter ablation, prolonged HV interval, chronic obstructive pulmonary disease, obstructive sleep apnea, or a higher HATCH score. These features should lower the threshold for extended ambulatory rhythm monitoring when anticoagulation decisions depend on whether AF recurs. [21]" ], "bullets": [ "Before elective cardioversion or ablation, document the current anticoagulant, adherence, renal function relevant to anticoagulant selection, bleeding history, and whether the patient has coexisting AF. [4][21][23]", "After CTI ablation, reassess stroke risk and rhythm status rather than treating procedural success as a substitute for anticoagulation decision-making. [21]", "Use extended ambulatory rhythm monitoring when postablation AF detection will change anticoagulation or rhythm-management decisions. [14][21]" ], "subsections": [], "table": { "caption": "Features that should prompt intensified post-flutter-ablation surveillance", "columns": [ "Feature", "Why it changes follow-up", "Practical implication" ], "rows": [ [ "Left-atrial enlargement or inducible AF at CTI ablation", "Predicts AF after flutter ablation. [21]", "Arrange longitudinal rhythm surveillance before relying on apparent flutter cure for treatment decisions. [21]" ], [ "COPD, obstructive sleep apnea, prolonged HV interval, or elevated HATCH score", "Associated with AF after flutter ablation. [21]", "Address modifiable comorbidity and use a lower threshold for ambulatory monitoring. [21][20]" ], [ "Prior thromboembolic event or ongoing indication for anticoagulation", "Postablation thromboembolic events occur despite successful flutter ablation. [21]", "Do not stop anticoagulation solely because sinus rhythm is documented after ablation. [21]" ] ] } }, { "id": "rhythm-control-and-ablation", "eyebrow": "Definitive therapy", "heading": "Use CTI ablation for typical flutter and mapping-guided ablation for atypical circuits", "intro": "The most durable rhythm-control decision depends on whether the flutter circuit is CTI dependent.", "paragraphs": [ "For documented typical flutter, CTI ablation is a safe and effective definitive treatment directed at the critical isthmus between the tricuspid annulus and inferior vena cava. Because the lesion set is anatomical, the patient does not need to be in flutter at the time of ablation. [14]", "Refer patients with recurrent symptomatic typical flutter, poor tolerance of rapid ventricular response, or concern for tachycardia-mediated ventricular dysfunction for electrophysiology evaluation of CTI ablation. The procedural aim is durable interruption of the CTI-dependent circuit; rhythm control is particularly relevant when atrial tachyarrhythmia is contributing to ventricular dysfunction or heart failure. [14][9][10]", "For flutter after left-atrial AF ablation, the procedural sequence matters. Perform CTI entrainment early, including when inferior leads are not negative, because CTI-dependent flutter can present with altered ECG morphology after left-atrial lesions. If CTI dependence is excluded, proceed with left-atrial activation and entrainment mapping to define the postablation macroreentrant circuit. [8][15]", "Counsel patients undergoing CTI ablation that successful treatment of the presenting flutter does not prevent later AF. Decision-making should therefore include both the high likelihood of eliminating a CTI-dependent circuit and the need for continued risk-factor management, rhythm surveillance, and individualized anticoagulation decisions. [14][21][20]" ], "bullets": [ "Typical CTI-dependent flutter: select an anatomic CTI ablation strategy. [14]", "Post–left atrial ablation flutter: establish CTI dependence with entrainment before committing to left-atrial mapping. [8]", "Incessant or highly frequent atrial tachyarrhythmia with reduced LVEF: pursue durable arrhythmia suppression because ventricular dysfunction may be reversible after successful ablation or control. [9][10]" ], "subsections": [ { "heading": "When the presenting rhythm is atypical", "paragraphs": [ "Atypical flutter should be treated as a mapping problem, not as a diagnosis established by a single ECG morphology. Surgical Maze and prior catheter-ablation lines can create anterior, roof-dependent, or septal left-atrial circuits, often in low-voltage tissue where surface ECG inference is insufficient for lesion planning. [15]" ], "bullets": [ "Obtain prior operative and ablation reports before repeat electrophysiology study; prior lesion sets materially alter the likely circuit. [15]", "If the patient had prior AF ablation, include CTI entrainment despite an ECG appearance that suggests left-atrial flutter. [8]" ] } ], "table": { "caption": "Ablation pathway by flutter substrate", "columns": [ "Clinical substrate", "Preferred electrophysiology question", "Ablation approach" ], "rows": [ [ "No prior left-atrial procedure and ECG consistent with typical flutter", "Is the circuit CTI dependent?", "Anatomic CTI ablation; flutter need not be present during the procedure. [14]" ], [ "Flutter after AF ablation", "Is the circuit CTI dependent despite nonclassic ECG morphology?", "Perform early CTI entrainment; avoid unnecessary initial transseptal mapping if CTI dependence is confirmed. [8]" ], [ "Prior Maze or complex left-atrial ablation", "Which macroreentrant circuit traverses incomplete or low-voltage atrial tissue?", "Use activation and entrainment mapping to guide left-atrial ablation. [15]" ] ] } }, { "id": "longitudinal-management", "eyebrow": "After rhythm control", "heading": "Monitor for atrial fibrillation, ventricular recovery, and modifiable recurrence drivers", "intro": "Follow-up should focus on the residual AF substrate rather than only recurrence of the index flutter circuit.", "paragraphs": [ "After cardioversion or CTI ablation, obtain symptom-directed ECG documentation and use ambulatory rhythm monitoring when recurrent AF would alter anticoagulation, antiarrhythmic strategy, or referral for AF ablation. This is especially important because AF after flutter ablation is associated with identifiable predictors and because stroke continues to occur in long-term follow-up cohorts. [21]", "Reassess ventricular function when flutter was persistent, poorly rate controlled, or associated with new heart failure. Tachycardia-mediated cardiomyopathy has been described with incessant atrial tachycardia, and successful catheter ablation can be associated with normalization of LV function in recurrent cases controlled after ablation or drug therapy. [9][10]", "Treat the arrhythmia substrate alongside the presenting rhythm. Hypertension, coronary disease, valvular disease, heart failure, obesity, sleep apnea, and pulmonary disease frequently coexist with AF and flutter; contemporary guideline frameworks emphasize proactive management of comorbidities and risk factors for all patients with AF. [4][20]" ], "bullets": [ "Document whether each recurrence is CTI flutter, AF, focal atrial tachycardia, or atypical macroreentrant flutter; the rhythm diagnosis determines whether repeat CTI ablation, AF-directed therapy, or remapping is appropriate. [8][14][15]", "Reevaluate anticoagulation whenever AF is detected, stroke-risk profile changes, or a planned procedure requires interruption. [21][23]", "Screen for and address obstructive sleep apnea and other comorbid drivers in patients with recurrent atrial arrhythmias or AF after flutter ablation. [4][20][21]" ], "subsections": [], "table": { "caption": "Post-treatment follow-up priorities", "columns": [ "Follow-up issue", "Trigger", "Action" ], "rows": [ [ "Incident AF", "Palpitations, irregular pulse, unexplained dyspnea, or high-risk postablation substrate", "Obtain ECG or ambulatory monitoring and revisit anticoagulation and AF rhythm-control decisions. [21]" ], [ "Possible tachycardia-mediated cardiomyopathy", "Reduced LVEF or heart-failure syndrome during persistent tachyarrhythmia", "Repeat echocardiographic assessment after durable arrhythmia control. [9][10]" ], [ "Atypical recurrence after prior AF ablation", "Flutter morphology differs from baseline or does not fit a classic CTI pattern", "Refer for mapping-guided electrophysiology evaluation; include CTI entrainment early. [8][15]" ] ] } } ], "faq": [ { "question": "Can anticoagulation be stopped after successful CTI ablation?", "answer": "Do not base discontinuation on ablation success alone. New-onset AF occurred in 38% in one post-flutter-ablation study, with thromboembolic events reported during long-term follow-up; reassess stroke risk and monitor for AF. [21]" }, { "question": "Does an atypical ECG after AF ablation exclude CTI-dependent flutter?", "answer": "No. After left-atrial AF ablation, 60% of patients with CTI-dependent flutter had upright inferior-lead flutter waves; perform CTI entrainment early before assuming a left-atrial circuit. [8]" } ], "references": [ { "number": 1, "title": "Atrial flutter - Guidelines | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/3000224/guidelines", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 2, "title": "Atrial Fibrillation - The New England Journal of Medicine", "detail": "www.nejm.org", "url": "https://www.nejm.org/doi/full/10.1056/NEJMcp2023658", "authors": "www.nejm.org", "host": "www.nejm.org" }, { "number": 3, "title": "Drugs for Atrial Fibrillation - JAMA Network", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jama/fullarticle/2754788", "authors": "jamanetwork.com", "host": "jamanetwork.com" }, { "number": 4, "title": "Established atrial fibrillation - Symptoms, diagnosis and treatment", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/1", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 5, "title": "Comparison of the Latest ESC, ACC/AHA/ACCP/HRS, and CCS Guidelines on the Management of Atrial Fibrillation", "detail": "www.jacc.org", "url": "https://www.jacc.org/doi/10.1016/j.jacep.2024.12.018", "authors": "www.jacc.org", "host": "www.jacc.org" }, { "number": 6, "title": "2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Circulation", "detail": "www.ahajournals.org", "url": "https://www.ahajournals.org/doi/10.1161/cir.0b013e318214876d", "authors": "www.ahajournals.org", "host": "www.ahajournals.org" }, { "number": 7, "title": "How to Manage Atrial Fibrillation: 2023 Guidelines - JACC", "detail": "www.jacc.org", "url": "https://www.jacc.org/guidelines/atrial-fibrillation", "authors": "www.jacc.org", "host": "www.jacc.org" }, { "number": 8, "title": "Characteristics of Cavotricuspid Isthmus–Dependent Atrial Flutter After Left Atrial Ablation of Atrial Fibrillation | Circulation", "detail": "www.ahajournals.org", "url": "https://www.ahajournals.org/doi/10.1161/circulationaha.105.580936", "authors": "www.ahajournals.org", "host": "www.ahajournals.org" }, { "number": 9, "title": "Tachycardia-Mediated Cardiomyopathy Secondary to Focal Atrial Tachycardia: Long-Term Outcome After Catheter Ablation | JACC", "detail": "www.jacc.org", "url": "https://www.jacc.org/doi/10.1016/j.jacc.2009.02.014", "authors": "www.jacc.org", "host": "www.jacc.org" }, { "number": 10, "title": "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation | Circulation", "detail": "www.ahajournals.org", "url": "https://www.ahajournals.org/doi/10.1161/cir.0000000000000041", "authors": "www.ahajournals.org", "host": "www.ahajournals.org" }, { "number": 11, "title": "Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy | JACC: Clinical Electrophysiology", "detail": "www.jacc.org", "url": "https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.03.026", "authors": "www.jacc.org", "host": "www.jacc.org" }, { "number": 12, "title": "Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0828282X21003135", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 13, "title": "Comparison of the Latest ESC, ACC/AHA/ACCP/HRS, and CCS Guidelines on the Management of Atrial Fibrillation - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S2405500X24010417", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 14, "title": "Heart Atrium Flutter - an overview", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/nursing-and-health-professions/heart-atrium-flutter", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 15, "title": "Atrial Flutter - an overview", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/neuroscience/atrial-flutter", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 16, "title": "Early recurrence of atrial tachyarrhythmia after catheter ablation and ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/europace/article/28/7/euag173/8726006", "authors": "academic.oup.com", "host": "academic.oup.com" }, { "number": 17, "title": "Catheter ablation for atrial fibrillation: indications and future ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/eurheartj/article/45/41/4383/7775548", "authors": "academic.oup.com", "host": "academic.oup.com" }, { "number": 18, "title": "Catheter ablation for atrial fibrillation and impact on clinical outcomes", "detail": "academic.oup.com", "url": "https://academic.oup.com/ehjopen/article/4/4/oeae058/7713667", "authors": "academic.oup.com", "host": "academic.oup.com" }, { "number": 19, "title": "Clinical outcomes of catheter ablation for atrial fibrillation, atrial ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/europace/article/26/6/euae155/7699724", "authors": "academic.oup.com", "host": "academic.oup.com" }, { "number": 20, "title": "A comparative review of current international atrial fibrillation ... - PMC", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12258508", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 21, "title": "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11095842", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 22, "title": "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PubMed", "detail": "pubmed.ncbi.nlm.nih.gov", "url": "https://pubmed.ncbi.nlm.nih.gov/38033089", "authors": "pubmed.ncbi.nlm.nih.gov", "host": "pubmed.ncbi.nlm.nih.gov" }, { "number": 23, "title": "New ACC/AHA Guideline Focuses on Diagnosis, Management of AFib - American College of Cardiology", "detail": "www.acc.org", "url": "https://www.acc.org/latest-in-cardiology/articles/2023/11/29/18/58/new-acc-aha-guideline-focuses-on-diagnosis-management-of-afib-gl-af", "authors": "www.acc.org", "host": "www.acc.org" }, { "number": 24, "title": "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and ...", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11104284", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" } ], "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.", "citations": [ { "number": 1, "title": "Atrial flutter - Guidelines | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/3000224/guidelines", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "Title: Atrial flutter - Guidelines | BMJ Best Practice\n# Atrial flutter. ## International guidelines. ### Resuscitation guidelines. Published by:Resuscitation Council UK. ### Atrial fibrillation: diagnosis and management. Published by:National Institute for Health and Care Excellence. ### Cardiac ar", "score": 0.86108357 }, { "number": 2, "title": "Atrial Fibrillation - The New England Journal of Medicine", "detail": "www.nejm.org", "url": "https://www.nejm.org/doi/full/10.1056/NEJMcp2023658", "authors": "www.nejm.org", "host": "www.nejm.org", "snippet": "Catheter ablation is more effective than antiarrhythmic drug therapy, serious complications included cardiac perforation with tamponade (in 0.8", "score": 0.586926 }, { "number": 3, "title": "Drugs for Atrial Fibrillation - JAMA Network", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jama/fullarticle/2754788", "authors": "jamanetwork.com", "host": "jamanetwork.com", "snippet": "Complications are rare but can be fatal. In symptomatic patients with heart failure and a reduced ejection fraction, catheter ablation may", "score": 0.40584955 }, { "number": 4, "title": "Established atrial fibrillation - Symptoms, diagnosis and treatment", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/1", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "Sharma M, Cornelius VR, Patel JP, et al. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-analysis. Circulation. 2015 Jul 21;132(3):194-204.Full textAbstract\n\nLi", "score": 0.31700373 }, { "number": 5, "title": "Comparison of the Latest ESC, ACC/AHA/ACCP/HRS, and CCS Guidelines on the Management of Atrial Fibrillation", "detail": "www.jacc.org", "url": "https://www.jacc.org/doi/10.1016/j.jacep.2024.12.018", "authors": "www.jacc.org", "host": "www.jacc.org", "snippet": "The ESC and ACC/AHA/ACCP/HRS guidelines both conclude with sections on gaps in evidence and future directions. These sections identify areas where scientific evidence is lacking and highlight emerging research frontiers. A comparative overview of the ESC and ACC/AHA/ACCP/HRS guidelines is presented ", "score": 0.8259413 }, { "number": 6, "title": "2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Circulation", "detail": "www.ahajournals.org", "url": "https://www.ahajournals.org/doi/10.1161/cir.0b013e318214876d", "authors": "www.ahajournals.org", "host": "www.ahajournals.org", "snippet": "# 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. The ACC/AHA/ESC Writing Committee to ", "score": 0.7123327 }, { "number": 7, "title": "How to Manage Atrial Fibrillation: 2023 Guidelines - JACC", "detail": "www.jacc.org", "url": "https://www.jacc.org/guidelines/atrial-fibrillation", "authors": "www.jacc.org", "host": "www.jacc.org", "snippet": "Open Access ##### 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance MeasuresJACC. 2021 Jan, 77 (3) 326-341 \n Free Acce", "score": 0.6937432 }, { "number": 8, "title": "Characteristics of Cavotricuspid Isthmus–Dependent Atrial Flutter After Left Atrial Ablation of Atrial Fibrillation | Circulation", "detail": "www.ahajournals.org", "url": "https://www.ahajournals.org/doi/10.1161/circulationaha.105.580936", "authors": "www.ahajournals.org", "host": "www.ahajournals.org", "snippet": "The flutter waves in the inferior leads were upright in 9 of the 15 patients (60%) with prior LA ablation and in none of the control subjects (*P*<0.001). In patients presenting with atrial flutter after LA ablation, entrainment mapping should be performed at the CTI even if the ECG is uncharacteris", "score": 0.7923522 }, { "number": 9, "title": "Tachycardia-Mediated Cardiomyopathy Secondary to Focal Atrial Tachycardia: Long-Term Outcome After Catheter Ablation | JACC", "detail": "www.jacc.org", "url": "https://www.jacc.org/doi/10.1016/j.jacc.2009.02.014", "authors": "www.jacc.org", "host": "www.jacc.org", "snippet": "Title: Tachycardia-Mediated Cardiomyopathy Secondary to Focal Atrial Tachycardia: Long-Term Outcome After Catheter Ablation | JACC\nThis study aimed to characterize the incidence, clinical and electrophysiologic features, and long-term outcomes of patients with tachycardia-mediated cardiomyopathy (TC", "score": 0.7192461 }, { "number": 10, "title": "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation | Circulation", "detail": "www.ahajournals.org", "url": "https://www.ahajournals.org/doi/10.1161/cir.0000000000000041", "authors": "www.ahajournals.org", "host": "www.ahajournals.org", "snippet": "# 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Key search words included but were not limited to the following: _age_, _ant", "score": 0.7152057 }, { "number": 11, "title": "Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy | JACC: Clinical Electrophysiology", "detail": "www.jacc.org", "url": "https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.03.026", "authors": "www.jacc.org", "host": "www.jacc.org", "snippet": "# Atrial Fibrillation Substrate and Catheter Ablation Outcomes in *MYBPC3*- and *MYH7*-Mediated Hypertrophic Cardiomyopathy. The aim of this study was to characterize the atrial substrate of patients with *MYBPC3*- or *MYH7*-mediated hypertrophic cardiomyopathy (HCM) and its impact on catheter ablat", "score": 0.5809471 }, { "number": 12, "title": "Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0828282X21003135", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Title: Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines - ScienceDirect\nGiven its complexity, the management of atrial fibrillation (AF) has relied increasingly on expert guideline recommendations; however, discrepancies betwee", "score": 0.82761955 }, { "number": 13, "title": "Comparison of the Latest ESC, ACC/AHA/ACCP/HRS, and CCS Guidelines on the Management of Atrial Fibrillation - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S2405500X24010417", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Overview of comparison of the current European Society of Cardiology (ESC) guideline recommendations, new aspects, and developments with the American College of Cardiology, the American Heart Association, the American College of Clinical Pharmacy, and the Heart Rhythm Society (ACC/AHA/ACCP/HRS) guid", "score": 0.80625874 }, { "number": 14, "title": "Heart Atrium Flutter - an overview", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/nursing-and-health-professions/heart-atrium-flutter", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Atrial flutter is a macroreentrant arrhythmia. When it perpetuates in a counterclockwise direction around the atrial side of the tricuspid valve, which can be identified by the 12-lead ECG, it is called “typical” AFL. Typical AFL is cavotricuspid isthmus dependent, which means that the region extend", "score": 0.7498395 }, { "number": 15, "title": "Atrial Flutter - an overview", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/neuroscience/atrial-flutter", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "#### Electrophysiologic Characteristics\n\nIn counterclockwise typical AFL, the impulse travels through the low septum, ascends superiorly and anteriorly up the septal and posterior walls of the right atrium, and descends over the anterior and lateral free wall.21 Finally, the circuit is completed acr", "score": 0.69795954 }, { "number": 16, "title": "Early recurrence of atrial tachyarrhythmia after catheter ablation and ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/europace/article/28/7/euag173/8726006", "authors": "academic.oup.com", "host": "academic.oup.com", "snippet": "In our study, ERAT occurring beyond approximately 60 days after ablation was associated with persistently elevated AF burden, a higher risk of late recurrence,", "score": 0.57236487 }, { "number": 17, "title": "Catheter ablation for atrial fibrillation: indications and future ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/eurheartj/article/45/41/4383/7775548", "authors": "academic.oup.com", "host": "academic.oup.com", "snippet": "Approximately 30%–40% of patients are known to experience recurrence after the first ablation procedure.20 The 2020 ESC Guideline and the 2023", "score": 0.4403014 }, { "number": 18, "title": "Catheter ablation for atrial fibrillation and impact on clinical outcomes", "detail": "academic.oup.com", "url": "https://academic.oup.com/ehjopen/article/4/4/oeae058/7713667", "authors": "academic.oup.com", "host": "academic.oup.com", "snippet": "All primary endpoints were significantly reduced by catheter ablation when compared to medical management: all-cause mortality, all-cause hospitalization, and", "score": 0.41037872 }, { "number": 19, "title": "Clinical outcomes of catheter ablation for atrial fibrillation, atrial ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/europace/article/26/6/euae155/7699724", "authors": "academic.oup.com", "host": "academic.oup.com", "snippet": "The outcomes of CA for ATTRwt-CM were acceptable, except for multiple focal AT and complex AFL. Catheter ablation may be aggressively considered", "score": 0.40098447 }, { "number": 20, "title": "A comparative review of current international atrial fibrillation ... - PMC", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12258508", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "## :4043-4140. doi: 10.1093/eurheartj/ehad192 [DOI] [PubMed] [Google Scholar]\n 2..Joglar JA, Chung MK, Armbruster AL, _et al_. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Co", "score": 0.80771893 }, { "number": 21, "title": "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11095842", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "4. Factors that predict AF after flutter ablation include LA enlargement,19–21 inducible AF at the time of flutter ablation,22,23 interatrial conduction time,24 prolonged HV interval,25 COPD,26 obstructive sleep apnea,20 and HATCH (hypertension, age ≥75 years, TIA or stroke, COPD, heart failure) s", "score": 0.79215926 }, { "number": 22, "title": "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PubMed", "detail": "pubmed.ncbi.nlm.nih.gov", "url": "https://pubmed.ncbi.nlm.nih.gov/38033089", "authors": "pubmed.ncbi.nlm.nih.gov", "host": "pubmed.ncbi.nlm.nih.gov", "snippet": "Atrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally. Recommendations from the \"2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation\" and the \"2019 AHA/ACC/HRS Focused Update of th", "score": 0.7644879 }, { "number": 23, "title": "New ACC/AHA Guideline Focuses on Diagnosis, Management of AFib - American College of Cardiology", "detail": "www.acc.org", "url": "https://www.acc.org/latest-in-cardiology/articles/2023/11/29/18/58/new-acc-aha-guideline-focuses-on-diagnosis-management-of-afib-gl-af", "authors": "www.acc.org", "host": "www.acc.org", "snippet": "JACC Central Illustration\n\nThe 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation updates two separate guidelines from 2014 and 2019, respectively, and includes new recommendations addressing AFib and thromboembolic risk assessment, anticoagulation, left atrial a", "score": 0.7644879 }, { "number": 24, "title": "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and ...", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11104284", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "## 11. FUTURE RESEARCH NEEDS\n\nEnormous progress and important advances have been made in recent years on the understanding of mechanisms and on the prevention and management of AF, including substantial progress since the 2014 guideline, as well as the 2019 focused update. Although the writing commi", "score": 0.7602419 } ], "publishedAt": "2026-09-15T22:36:28.949174+00:00", "updatedAt": "2026-09-15T22:36:28.949174+00:00", "readingMinutes": 6, "slug": "atrial-flutter" }